Company Filing History:
Years Active: 2025
Title: Andreas Heinrich Neerincx: Innovator in Peptide-Exchange Proteins
Introduction
Andreas Heinrich Neerincx is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of peptide-exchange proteins. His work has the potential to impact immune response modulation, which is crucial in various medical applications.
Latest Patents
Neerincx holds a patent for a peptide-exchange protein. This invention relates to peptide-exchange proteins comprising the luminal domain of TAP-binding protein-related (TAPBPR). These proteins function as MHC class I peptide-exchange catalysts when presented to mammalian cells, either as soluble extracellular proteins or as membrane-bound cell surface proteins. This innovation may be useful in modulating immune responses, such as loading immunogenic peptides onto tumors or other disease cells to induce their recognition by T cells. The patent provides methods for the use of peptide-exchange proteins.
Career Highlights
Andreas Neerincx is associated with Cambridge Enterprise Limited, where he continues to advance his research and innovations. His work is characterized by a commitment to enhancing therapeutic strategies through innovative protein engineering.
Collaborations
Neerincx has collaborated with notable colleagues, including Louise Helen Boyle and Florin Tudor Ilca. These partnerships have contributed to the development and refinement of his inventions.
Conclusion
Andreas Heinrich Neerincx is a pioneering inventor whose work in peptide-exchange proteins holds promise for advancing medical therapies. His contributions to biotechnology are noteworthy and reflect his dedication to innovation in the field.